nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenoldopam—DRD1—telencephalic ventricle—malignant glioma	0.0741	0.156	CbGeAlD
Fenoldopam—DRD2—telencephalic ventricle—malignant glioma	0.0438	0.0919	CbGeAlD
Fenoldopam—DRD5—telencephalon—malignant glioma	0.0233	0.0489	CbGeAlD
Fenoldopam—DRD1—brainstem—malignant glioma	0.0201	0.0421	CbGeAlD
Fenoldopam—ADRA1D—telencephalon—malignant glioma	0.0187	0.0392	CbGeAlD
Fenoldopam—DRD1—telencephalon—malignant glioma	0.0178	0.0374	CbGeAlD
Fenoldopam—DRD5—central nervous system—malignant glioma	0.0132	0.0278	CbGeAlD
Fenoldopam—DRD1—midbrain—malignant glioma	0.0128	0.0268	CbGeAlD
Fenoldopam—ADRA1A—brainstem—malignant glioma	0.0121	0.0254	CbGeAlD
Fenoldopam—DRD2—brainstem—malignant glioma	0.0119	0.0249	CbGeAlD
Fenoldopam—Transaminases increased—Carmustine—malignant glioma	0.0115	0.0872	CcSEcCtD
Fenoldopam—DRD2—retina—malignant glioma	0.0114	0.024	CbGeAlD
Fenoldopam—ADRA1B—central nervous system—malignant glioma	0.0109	0.0228	CbGeAlD
Fenoldopam—ADRA1A—telencephalon—malignant glioma	0.0107	0.0225	CbGeAlD
Fenoldopam—ADRA1D—central nervous system—malignant glioma	0.0106	0.0223	CbGeAlD
Fenoldopam—DRD2—telencephalon—malignant glioma	0.0105	0.0221	CbGeAlD
Fenoldopam—DRD5—brain—malignant glioma	0.0105	0.0221	CbGeAlD
Fenoldopam—ADRA2C—telencephalon—malignant glioma	0.0102	0.0215	CbGeAlD
Fenoldopam—DRD1—central nervous system—malignant glioma	0.0101	0.0212	CbGeAlD
Fenoldopam—ADRA1B—brain—malignant glioma	0.00862	0.0181	CbGeAlD
Fenoldopam—ADRA1D—brain—malignant glioma	0.00843	0.0177	CbGeAlD
Fenoldopam—ADRA2A—telencephalon—malignant glioma	0.00816	0.0171	CbGeAlD
Fenoldopam—ADRA2C—medulla oblongata—malignant glioma	0.00803	0.0169	CbGeAlD
Fenoldopam—DRD1—brain—malignant glioma	0.00803	0.0169	CbGeAlD
Fenoldopam—DRD2—midbrain—malignant glioma	0.00755	0.0159	CbGeAlD
Fenoldopam—Leukocytosis—Carmustine—malignant glioma	0.00747	0.0565	CcSEcCtD
Fenoldopam—ADRA2C—midbrain—malignant glioma	0.00734	0.0154	CbGeAlD
Fenoldopam—ADRA2C—spinal cord—malignant glioma	0.00716	0.015	CbGeAlD
Fenoldopam—Injection site reaction—Carmustine—malignant glioma	0.00698	0.0527	CcSEcCtD
Fenoldopam—ADRA2A—medulla oblongata—malignant glioma	0.00641	0.0135	CbGeAlD
Fenoldopam—ADRA1A—central nervous system—malignant glioma	0.0061	0.0128	CbGeAlD
Fenoldopam—DRD2—central nervous system—malignant glioma	0.00598	0.0125	CbGeAlD
Fenoldopam—ADRA1A—cerebellum—malignant glioma	0.00596	0.0125	CbGeAlD
Fenoldopam—ADRA2A—midbrain—malignant glioma	0.00586	0.0123	CbGeAlD
Fenoldopam—DRD2—cerebellum—malignant glioma	0.00584	0.0123	CbGeAlD
Fenoldopam—ADRA2C—central nervous system—malignant glioma	0.00581	0.0122	CbGeAlD
Fenoldopam—ADRA2A—spinal cord—malignant glioma	0.00572	0.012	CbGeAlD
Fenoldopam—ADRA2C—cerebellum—malignant glioma	0.00568	0.0119	CbGeAlD
Fenoldopam—Nasal congestion—Temozolomide—malignant glioma	0.00541	0.0409	CcSEcCtD
Fenoldopam—ADRA1A—brain—malignant glioma	0.00484	0.0102	CbGeAlD
Fenoldopam—DRD2—brain—malignant glioma	0.00475	0.00996	CbGeAlD
Fenoldopam—Hypokalaemia—Carmustine—malignant glioma	0.00464	0.0351	CcSEcCtD
Fenoldopam—ADRA2A—central nervous system—malignant glioma	0.00464	0.00973	CbGeAlD
Fenoldopam—ADRA2C—brain—malignant glioma	0.00461	0.00968	CbGeAlD
Fenoldopam—ADRA2A—cerebellum—malignant glioma	0.00453	0.00951	CbGeAlD
Fenoldopam—Hypokalaemia—Temozolomide—malignant glioma	0.00448	0.0339	CcSEcCtD
Fenoldopam—Urinary tract infection—Carmustine—malignant glioma	0.00382	0.0288	CcSEcCtD
Fenoldopam—Urinary tract infection—Temozolomide—malignant glioma	0.00369	0.0279	CcSEcCtD
Fenoldopam—ADRA2A—brain—malignant glioma	0.00368	0.00773	CbGeAlD
Fenoldopam—Haemoglobin—Carmustine—malignant glioma	0.00354	0.0268	CcSEcCtD
Fenoldopam—Haemorrhage—Carmustine—malignant glioma	0.00353	0.0266	CcSEcCtD
Fenoldopam—Haemoglobin—Temozolomide—malignant glioma	0.00343	0.0259	CcSEcCtD
Fenoldopam—Haemorrhage—Temozolomide—malignant glioma	0.00341	0.0257	CcSEcCtD
Fenoldopam—Flushing—Carmustine—malignant glioma	0.00327	0.0247	CcSEcCtD
Fenoldopam—Flushing—Temozolomide—malignant glioma	0.00316	0.0239	CcSEcCtD
Fenoldopam—Back pain—Carmustine—malignant glioma	0.00297	0.0224	CcSEcCtD
Fenoldopam—Back pain—Temozolomide—malignant glioma	0.00287	0.0217	CcSEcCtD
Fenoldopam—Palpitations—Temozolomide—malignant glioma	0.00262	0.0198	CcSEcCtD
Fenoldopam—Chest pain—Carmustine—malignant glioma	0.00261	0.0197	CcSEcCtD
Fenoldopam—Anxiety—Carmustine—malignant glioma	0.0026	0.0197	CcSEcCtD
Fenoldopam—Anxiety—Temozolomide—malignant glioma	0.00252	0.019	CcSEcCtD
Fenoldopam—Tachycardia—Carmustine—malignant glioma	0.00245	0.0185	CcSEcCtD
Fenoldopam—Hypotension—Carmustine—malignant glioma	0.00234	0.0177	CcSEcCtD
Fenoldopam—Hyperhidrosis—Temozolomide—malignant glioma	0.00234	0.0177	CcSEcCtD
Fenoldopam—Insomnia—Carmustine—malignant glioma	0.00227	0.0171	CcSEcCtD
Fenoldopam—Dyspnoea—Carmustine—malignant glioma	0.00223	0.0169	CcSEcCtD
Fenoldopam—Insomnia—Temozolomide—malignant glioma	0.00219	0.0165	CcSEcCtD
Fenoldopam—Dyspnoea—Temozolomide—malignant glioma	0.00216	0.0163	CcSEcCtD
Fenoldopam—Constipation—Carmustine—malignant glioma	0.00214	0.0162	CcSEcCtD
Fenoldopam—Constipation—Temozolomide—malignant glioma	0.00207	0.0156	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Carmustine—malignant glioma	0.00205	0.0155	CcSEcCtD
Fenoldopam—Body temperature increased—Carmustine—malignant glioma	0.00198	0.015	CcSEcCtD
Fenoldopam—Abdominal pain—Carmustine—malignant glioma	0.00198	0.015	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Temozolomide—malignant glioma	0.00198	0.015	CcSEcCtD
Fenoldopam—Abdominal pain—Temozolomide—malignant glioma	0.00191	0.0145	CcSEcCtD
Fenoldopam—Body temperature increased—Temozolomide—malignant glioma	0.00191	0.0145	CcSEcCtD
Fenoldopam—Diarrhoea—Carmustine—malignant glioma	0.00171	0.013	CcSEcCtD
Fenoldopam—Dizziness—Carmustine—malignant glioma	0.00166	0.0125	CcSEcCtD
Fenoldopam—Diarrhoea—Temozolomide—malignant glioma	0.00166	0.0125	CcSEcCtD
Fenoldopam—Dizziness—Temozolomide—malignant glioma	0.0016	0.0121	CcSEcCtD
Fenoldopam—Vomiting—Carmustine—malignant glioma	0.00159	0.012	CcSEcCtD
Fenoldopam—Headache—Carmustine—malignant glioma	0.00157	0.0119	CcSEcCtD
Fenoldopam—Vomiting—Temozolomide—malignant glioma	0.00154	0.0116	CcSEcCtD
Fenoldopam—Headache—Temozolomide—malignant glioma	0.00152	0.0115	CcSEcCtD
Fenoldopam—Nausea—Carmustine—malignant glioma	0.00149	0.0112	CcSEcCtD
Fenoldopam—Nausea—Temozolomide—malignant glioma	0.00144	0.0109	CcSEcCtD
Fenoldopam—ADRA1A—Signaling Pathways—CAV1—malignant glioma	7.82e-05	0.0002	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—PIK3CA—malignant glioma	7.74e-05	0.000198	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—KDR—malignant glioma	7.73e-05	0.000198	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—FN1—malignant glioma	7.72e-05	0.000197	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—F2—malignant glioma	7.72e-05	0.000197	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MDM2—malignant glioma	7.71e-05	0.000197	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—RAF1—malignant glioma	7.68e-05	0.000196	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—PIK3CD—malignant glioma	7.67e-05	0.000196	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PDGFB—malignant glioma	7.66e-05	0.000196	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—BRAF—malignant glioma	7.66e-05	0.000196	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—PIK3CA—malignant glioma	7.64e-05	0.000195	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PPARG—malignant glioma	7.64e-05	0.000195	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—BAD—malignant glioma	7.63e-05	0.000195	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—FGFR1—malignant glioma	7.62e-05	0.000195	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MDM2—malignant glioma	7.61e-05	0.000194	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—ERBB2—malignant glioma	7.6e-05	0.000194	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—PIK3CA—malignant glioma	7.59e-05	0.000194	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—RAF1—malignant glioma	7.58e-05	0.000194	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—NOTCH1—malignant glioma	7.56e-05	0.000193	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—BRAF—malignant glioma	7.53e-05	0.000193	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—HIF1A—malignant glioma	7.51e-05	0.000192	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—KRAS—malignant glioma	7.5e-05	0.000192	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—PIK3CB—malignant glioma	7.5e-05	0.000192	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—ERBB2—malignant glioma	7.5e-05	0.000192	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—KRAS—malignant glioma	7.49e-05	0.000191	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—PIK3CB—malignant glioma	7.46e-05	0.000191	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—AKT2—malignant glioma	7.45e-05	0.000191	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—AKT1—malignant glioma	7.45e-05	0.00019	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—F2—malignant glioma	7.44e-05	0.00019	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—FN1—malignant glioma	7.44e-05	0.00019	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—EGFR—malignant glioma	7.42e-05	0.00019	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CD80—malignant glioma	7.4e-05	0.000189	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—PIK3CB—malignant glioma	7.4e-05	0.000189	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—PTGS2—malignant glioma	7.4e-05	0.000189	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—APC—malignant glioma	7.39e-05	0.000189	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PIK3CG—malignant glioma	7.39e-05	0.000189	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—BAD—malignant glioma	7.35e-05	0.000188	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—FGF2—malignant glioma	7.34e-05	0.000188	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—AKT2—malignant glioma	7.33e-05	0.000187	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—EGF—malignant glioma	7.31e-05	0.000187	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—EGFR—malignant glioma	7.3e-05	0.000187	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—NOTCH1—malignant glioma	7.28e-05	0.000186	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CAV1—malignant glioma	7.26e-05	0.000186	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PTPN11—malignant glioma	7.26e-05	0.000186	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CXCL8—malignant glioma	7.21e-05	0.000184	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—KDR—malignant glioma	7.18e-05	0.000184	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—PIK3CD—malignant glioma	7.16e-05	0.000183	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CD80—malignant glioma	7.13e-05	0.000182	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—APC—malignant glioma	7.12e-05	0.000182	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PIK3CG—malignant glioma	7.12e-05	0.000182	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CXCL8—malignant glioma	7.11e-05	0.000182	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—PIK3CA—malignant glioma	7.09e-05	0.000181	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PIK3CD—malignant glioma	7.05e-05	0.00018	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—EGF—malignant glioma	7.04e-05	0.00018	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—KRAS—malignant glioma	7.01e-05	0.000179	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PTPN11—malignant glioma	7e-05	0.000179	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—PIK3CA—malignant glioma	6.98e-05	0.000178	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—AKT1—malignant glioma	6.96e-05	0.000178	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PIK3CD—malignant glioma	6.96e-05	0.000178	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—BRAF—malignant glioma	6.95e-05	0.000178	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—F2—malignant glioma	6.91e-05	0.000177	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—FN1—malignant glioma	6.91e-05	0.000177	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—KRAS—malignant glioma	6.9e-05	0.000176	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CASP3—malignant glioma	6.9e-05	0.000176	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—PIK3CA—malignant glioma	6.89e-05	0.000176	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—IL2—malignant glioma	6.89e-05	0.000176	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—PIK3CA—malignant glioma	6.88e-05	0.000176	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—AKT1—malignant glioma	6.87e-05	0.000176	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MDM2—malignant glioma	6.87e-05	0.000176	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—FGF2—malignant glioma	6.86e-05	0.000175	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—RAF1—malignant glioma	6.84e-05	0.000175	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—BAD—malignant glioma	6.83e-05	0.000175	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CASP3—malignant glioma	6.81e-05	0.000174	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—IL2—malignant glioma	6.8e-05	0.000174	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—ERBB2—malignant glioma	6.77e-05	0.000173	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—NOTCH1—malignant glioma	6.77e-05	0.000173	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—AKT2—malignant glioma	6.76e-05	0.000173	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—FGF2—malignant glioma	6.75e-05	0.000172	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—EGFR—malignant glioma	6.73e-05	0.000172	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—BRAF—malignant glioma	6.69e-05	0.000171	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—PIK3CB—malignant glioma	6.68e-05	0.000171	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—TP53—malignant glioma	6.66e-05	0.00017	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CD80—malignant glioma	6.63e-05	0.000169	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—APC—malignant glioma	6.62e-05	0.000169	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PIK3CG—malignant glioma	6.62e-05	0.000169	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—EGF—malignant glioma	6.54e-05	0.000167	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MMP9—malignant glioma	6.52e-05	0.000167	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—AKT2—malignant glioma	6.51e-05	0.000167	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PTPN11—malignant glioma	6.5e-05	0.000166	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PIK3CD—malignant glioma	6.5e-05	0.000166	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—EGFR—malignant glioma	6.49e-05	0.000166	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—PTEN—malignant glioma	6.48e-05	0.000166	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—PTEN—malignant glioma	6.45e-05	0.000165	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—PIK3CA—malignant glioma	6.44e-05	0.000165	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—PIK3CA—malignant glioma	6.44e-05	0.000165	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MMP9—malignant glioma	6.43e-05	0.000164	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CXCL8—malignant glioma	6.42e-05	0.000164	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MDM2—malignant glioma	6.41e-05	0.000164	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—PTEN—malignant glioma	6.39e-05	0.000163	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—RAF1—malignant glioma	6.39e-05	0.000163	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—KRAS—malignant glioma	6.36e-05	0.000163	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—PIK3CA—malignant glioma	6.34e-05	0.000162	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—ERBB2—malignant glioma	6.32e-05	0.000162	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—AKT1—malignant glioma	6.32e-05	0.000162	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MDM2—malignant glioma	6.31e-05	0.000161	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—RAF1—malignant glioma	6.29e-05	0.000161	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PIK3CD—malignant glioma	6.26e-05	0.00016	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—PIK3CB—malignant glioma	6.24e-05	0.00016	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—AKT1—malignant glioma	6.24e-05	0.000159	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—ERBB2—malignant glioma	6.22e-05	0.000159	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—FGF2—malignant glioma	6.22e-05	0.000159	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—BRAF—malignant glioma	6.22e-05	0.000159	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—AKT1—malignant glioma	6.2e-05	0.000159	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—PIK3CA—malignant glioma	6.2e-05	0.000158	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CASP3—malignant glioma	6.15e-05	0.000157	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PIK3CB—malignant glioma	6.14e-05	0.000157	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—IL2—malignant glioma	6.14e-05	0.000157	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—KRAS—malignant glioma	6.13e-05	0.000157	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PIK3CB—malignant glioma	6.06e-05	0.000155	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—AKT2—malignant glioma	6.05e-05	0.000155	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—EGFR—malignant glioma	6.03e-05	0.000154	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PTGS2—malignant glioma	6.01e-05	0.000154	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CXCL8—malignant glioma	6e-05	0.000153	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—FGF2—malignant glioma	5.99e-05	0.000153	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CXCL8—malignant glioma	5.9e-05	0.000151	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—VEGFA—malignant glioma	5.85e-05	0.00015	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—PIK3CA—malignant glioma	5.84e-05	0.000149	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MDM2—malignant glioma	5.82e-05	0.000149	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PIK3CD—malignant glioma	5.82e-05	0.000149	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MMP9—malignant glioma	5.81e-05	0.000148	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—RAF1—malignant glioma	5.8e-05	0.000148	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—STAT3—malignant glioma	5.8e-05	0.000148	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—AKT1—malignant glioma	5.79e-05	0.000148	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—VEGFA—malignant glioma	5.78e-05	0.000148	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—PTEN—malignant glioma	5.77e-05	0.000148	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—PIK3CA—malignant glioma	5.76e-05	0.000147	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CASP3—malignant glioma	5.74e-05	0.000147	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—ERBB2—malignant glioma	5.74e-05	0.000147	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—IL2—malignant glioma	5.73e-05	0.000147	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—STAT3—malignant glioma	5.72e-05	0.000146	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—AKT1—malignant glioma	5.7e-05	0.000146	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—KRAS—malignant glioma	5.69e-05	0.000146	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PIK3CB—malignant glioma	5.66e-05	0.000145	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CASP3—malignant glioma	5.65e-05	0.000144	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—IL2—malignant glioma	5.64e-05	0.000144	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—AKT1—malignant glioma	5.63e-05	0.000144	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—PIK3CA—malignant glioma	5.63e-05	0.000144	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—AKT1—malignant glioma	5.62e-05	0.000144	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MDM2—malignant glioma	5.61e-05	0.000143	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—RAF1—malignant glioma	5.59e-05	0.000143	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—FGF2—malignant glioma	5.57e-05	0.000142	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—ERBB2—malignant glioma	5.53e-05	0.000141	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PIK3CB—malignant glioma	5.46e-05	0.000139	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CXCL8—malignant glioma	5.44e-05	0.000139	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MMP9—malignant glioma	5.42e-05	0.000139	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—PTEN—malignant glioma	5.39e-05	0.000138	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MYC—malignant glioma	5.39e-05	0.000138	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MMP9—malignant glioma	5.34e-05	0.000136	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MYC—malignant glioma	5.31e-05	0.000136	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PTEN—malignant glioma	5.31e-05	0.000136	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—EGFR—malignant glioma	5.27e-05	0.000135	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—AKT1—malignant glioma	5.26e-05	0.000135	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—AKT1—malignant glioma	5.26e-05	0.000134	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CXCL8—malignant glioma	5.24e-05	0.000134	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PTEN—malignant glioma	5.24e-05	0.000134	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—PIK3CA—malignant glioma	5.23e-05	0.000134	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—VEGFA—malignant glioma	5.21e-05	0.000133	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MDM2—malignant glioma	5.21e-05	0.000133	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CASP3—malignant glioma	5.21e-05	0.000133	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—IL2—malignant glioma	5.2e-05	0.000133	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—EGFR—malignant glioma	5.2e-05	0.000133	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—RAF1—malignant glioma	5.19e-05	0.000133	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—AKT1—malignant glioma	5.18e-05	0.000132	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—STAT3—malignant glioma	5.16e-05	0.000132	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—ERBB2—malignant glioma	5.14e-05	0.000131	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PIK3CB—malignant glioma	5.07e-05	0.00013	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—AKT1—malignant glioma	5.06e-05	0.000129	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CASP3—malignant glioma	5.02e-05	0.000128	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IL2—malignant glioma	5.01e-05	0.000128	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—KRAS—malignant glioma	4.98e-05	0.000127	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MMP9—malignant glioma	4.92e-05	0.000126	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—KRAS—malignant glioma	4.91e-05	0.000126	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PTEN—malignant glioma	4.89e-05	0.000125	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CXCL8—malignant glioma	4.87e-05	0.000125	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—VEGFA—malignant glioma	4.87e-05	0.000125	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—STAT3—malignant glioma	4.82e-05	0.000123	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MYC—malignant glioma	4.8e-05	0.000123	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—VEGFA—malignant glioma	4.79e-05	0.000123	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—AKT1—malignant glioma	4.77e-05	0.000122	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—STAT3—malignant glioma	4.75e-05	0.000121	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MMP9—malignant glioma	4.74e-05	0.000121	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PTEN—malignant glioma	4.71e-05	0.000121	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—AKT1—malignant glioma	4.71e-05	0.00012	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—EGFR—malignant glioma	4.69e-05	0.00012	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CASP3—malignant glioma	4.66e-05	0.000119	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IL2—malignant glioma	4.66e-05	0.000119	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—AKT1—malignant glioma	4.6e-05	0.000118	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—PIK3CA—malignant glioma	4.57e-05	0.000117	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—PIK3CA—malignant glioma	4.55e-05	0.000116	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—PIK3CA—malignant glioma	4.51e-05	0.000115	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MYC—malignant glioma	4.48e-05	0.000115	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—KRAS—malignant glioma	4.43e-05	0.000113	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—TP53—malignant glioma	4.42e-05	0.000113	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—VEGFA—malignant glioma	4.42e-05	0.000113	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MYC—malignant glioma	4.41e-05	0.000113	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MMP9—malignant glioma	4.41e-05	0.000113	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—EGFR—malignant glioma	4.38e-05	0.000112	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PTEN—malignant glioma	4.38e-05	0.000112	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—STAT3—malignant glioma	4.38e-05	0.000112	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—TP53—malignant glioma	4.36e-05	0.000112	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—EGFR—malignant glioma	4.31e-05	0.00011	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—AKT1—malignant glioma	4.27e-05	0.000109	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—VEGFA—malignant glioma	4.26e-05	0.000109	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—STAT3—malignant glioma	4.22e-05	0.000108	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—KRAS—malignant glioma	4.14e-05	0.000106	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—KRAS—malignant glioma	4.08e-05	0.000104	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—PIK3CA—malignant glioma	4.07e-05	0.000104	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MYC—malignant glioma	4.07e-05	0.000104	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—EGFR—malignant glioma	3.98e-05	0.000102	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—VEGFA—malignant glioma	3.96e-05	0.000101	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—TP53—malignant glioma	3.94e-05	0.000101	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MYC—malignant glioma	3.92e-05	0.0001	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—STAT3—malignant glioma	3.92e-05	0.0001	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—EGFR—malignant glioma	3.83e-05	9.8e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—PIK3CA—malignant glioma	3.8e-05	9.73e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—KRAS—malignant glioma	3.76e-05	9.61e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PIK3CA—malignant glioma	3.74e-05	9.57e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—AKT1—malignant glioma	3.74e-05	9.55e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—AKT1—malignant glioma	3.72e-05	9.5e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PIK3CA—malignant glioma	3.7e-05	9.45e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—AKT1—malignant glioma	3.69e-05	9.42e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—TP53—malignant glioma	3.68e-05	9.41e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MYC—malignant glioma	3.64e-05	9.31e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—TP53—malignant glioma	3.62e-05	9.26e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—KRAS—malignant glioma	3.62e-05	9.25e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—EGFR—malignant glioma	3.56e-05	9.1e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PIK3CA—malignant glioma	3.45e-05	8.83e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—KRAS—malignant glioma	3.36e-05	8.6e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—TP53—malignant glioma	3.34e-05	8.54e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—AKT1—malignant glioma	3.33e-05	8.51e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PIK3CA—malignant glioma	3.33e-05	8.5e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—TP53—malignant glioma	3.22e-05	8.23e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—AKT1—malignant glioma	3.11e-05	7.95e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PIK3CA—malignant glioma	3.09e-05	7.9e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—AKT1—malignant glioma	3.06e-05	7.82e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—AKT1—malignant glioma	3.02e-05	7.72e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—TP53—malignant glioma	2.99e-05	7.64e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—AKT1—malignant glioma	2.82e-05	7.21e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—AKT1—malignant glioma	2.72e-05	6.95e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—AKT1—malignant glioma	2.52e-05	6.45e-05	CbGpPWpGaD
